Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Vickers

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Modification of MyD88 mRNA splicing and inhibition of IL-1beta signaling in cell culture and in mice with a 2'-O-methoxyethyl-modified oligonucleotideTimothy A Vickers, Hong Zhang, Mark J Graham, et al.
Nucleic Acid Therapeutics|July 19, 2022
NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate OligonucleotidesLingdi Zhang, Karla D Bernardo, Timothy A Vickers, et al.
Nucleic Acids Research|July 18, 2022
Insights into innate immune activation via PS-ASO-protein-TLR9 interactionsAdam J Pollak, Luyi Zhao, Timothy A Vickers, et al.
Nucleic Acids Research|September 22, 2009
Off-target and a portion of target-specific siRNA mediated mRNA degradation is Ago2 'Slicer' independent and can be mediated by Ago1Timothy A Vickers, Walt F Lima, Hongjiang Wu, et al.
The Journal of Biological Chemistry|December 26, 2002
Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysisTimothy A Vickers, Seongjoon Koo, C Frank Bennett, et al.
Nucleic Acids Research|February 2, 2018
Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteinsWen Shen, Cheryl L De Hoyos, Hong Sun, et al.
Nucleic Acids Research|March 8, 2018
Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotidesShiyu Wang, Nickolas Allen, Timothy A Vickers, et al.
Nucleic Acids Research|December 17, 2019
Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomesXue-Hai Liang, Hong Sun, Chih-Wei Hsu, et al.
Nucleic Acids Research|September 22, 2018
COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathwaysXue-Hai Liang, Hong Sun, Joshua G Nichols, et al.
Journal of the American Chemical Society|March 24, 2020
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for ProteinsMalwina Hyjek-Składanowska, Timothy A Vickers, Agnieszka Napiórkowska, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Modification of MyD88 mRNA splicing and inhibition of IL-1beta signaling in cell culture and in mice with a 2'-O-methoxyethyl-modified oligonucleotideTimothy A Vickers, Hong Zhang, Mark J Graham, et al.
Nucleic Acid Therapeutics|July 19, 2022
NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate OligonucleotidesLingdi Zhang, Karla D Bernardo, Timothy A Vickers, et al.
Nucleic Acids Research|July 18, 2022
Insights into innate immune activation via PS-ASO-protein-TLR9 interactionsAdam J Pollak, Luyi Zhao, Timothy A Vickers, et al.
Nucleic Acids Research|September 22, 2009
Off-target and a portion of target-specific siRNA mediated mRNA degradation is Ago2 'Slicer' independent and can be mediated by Ago1Timothy A Vickers, Walt F Lima, Hongjiang Wu, et al.
The Journal of Biological Chemistry|December 26, 2002
Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysisTimothy A Vickers, Seongjoon Koo, C Frank Bennett, et al.
Nucleic Acids Research|February 2, 2018
Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteinsWen Shen, Cheryl L De Hoyos, Hong Sun, et al.
Nucleic Acids Research|March 8, 2018
Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotidesShiyu Wang, Nickolas Allen, Timothy A Vickers, et al.
Nucleic Acids Research|December 17, 2019
Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomesXue-Hai Liang, Hong Sun, Chih-Wei Hsu, et al.
Nucleic Acids Research|September 22, 2018
COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathwaysXue-Hai Liang, Hong Sun, Joshua G Nichols, et al.
Journal of the American Chemical Society|March 24, 2020
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for ProteinsMalwina Hyjek-Składanowska, Timothy A Vickers, Agnieszka Napiórkowska, et al.
Pageof 4